RecruitingNot ApplicableNCT05973656

Role of Acetaldehyde in the Development of Oral Cancer

Dissecting the Role of Acetaldehyde in Oral Carcinogenesis


Sponsor

Masonic Cancer Center, University of Minnesota

Enrollment

170 participants

Start Date

Jul 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria12

  • years of age for alcohol drinkers
  • Occasionally consume alcohol
  • At least 1 drink per month for healthy volunteers
  • At least 1 drink in the last 3 months for Fanconi anemia patients
  • Meets one of the three criteria
  • Healthy volunteer - ALDH2\*1/1\* homozygotes-not of Eastern Asian decent;
  • Healthy volunteer - ALDH2\*1/2\* heterozygotes-of Eastern Asian decent and experience flushing when drinking
  • Individual's with Fanconi anemia (FA).
  • years of age for non-drinkers
  • Never consume alcohol/not had alcohol in the last 6 months
  • Healthy volunteers.
  • Non-smoker (smoked \< 100 cigarettes in a lifetime)

Exclusion Criteria11

  • Pregnant or nursing
  • Taking any medication or drug that might affect alcohol use and absorption or that might be affected by alcohol consumption
  • Healthy volunteers who have taken any antibiotics in the last 3 months
  • Currently consuming more than 21 drinks per week
  • Have any history of alcohol or drug related problems
  • Current or former tobacco/nicotine product(s) user
  • Any regular use of tobacco/nicotine products or marijuana in the last year (cigarettes, e-cigarettes, cigars, pipes, smokeless tobacco)
  • "Trying" or limited use of any nicotine products or marijuana in the last 1 month
  • Active infection (influenza, cold, COVID, respiratory / sinus infection) - admission in the study will be delayed pending improved health
  • Non-FA volunteers who have an unstable medical condition or condition that could be affected by alcohol consumption (insulin-dependent diabetes, ulcers, heart issues)
  • Experience severe adverse events (nausea, blacking out) when consuming even low doses of alcohol

Interventions

DRUGAlcohol

Alcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC).

PROCEDUREBiospecimen Collection

Undergo saliva, mouthwash, and cheek brush collection

PROCEDUREBreath Test

Undergo breathalyzer testing


Locations(1)

Masonic Cancer Center, University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05973656


Related Trials